MNKD Q2 2025 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+5.7% YoY

Gross Profit

$56M73.1% margin

Operating Income

$5M6.9% margin

Net Income

$668,0000.9% margin

EPS (Diluted)

$0.00

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$8M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$412M

Total Liabilities

$467M

Stockholders' Equity

-$55M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$72M	+5.7%
Gross Profit	$56M	$52M	+7.6%
Operating Income	$5M	$17M	-68.1%
Net Income	$668,000	-$2M	+133.2%

Revenue Segments

Product Revenue

$45M58%

Royalty

$31M41%

Service

$621,0001%